Evidence map›Paper›PMID 32285113›Full record

ArticleSchizophrenia bulletin2020

Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity.

Hiroshi Komatsu, Hikaru Takeuchi, Yoshie Kikuchi, Chiaki Ono, Zhiqian Yu, Kunio Iizuka, Yuji Takano, Yoshihisa Kakuto, Shunichi Funakoshi, Takashi Ono and 19 more

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The role ofEpigenetics · 2026
    Review
  4. IncreasingBiological psychiatry global open science · 2025
    Article
  5. Article
  6. Article
  7. The Node of Ranvier as an Interface for Axo-Glial Interactions: Perturbation of Axo-Glial Interactions in Various Neurological Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Association BetweenFrontiers in psychiatry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 1 country.

Hiroshi KomatsuDepartment of Psychiatry, Miyagi Psychiatric Center, Natori, Japan.
Hikaru TakeuchiDivision of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Yoshie KikuchiDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Chiaki OnoDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Zhiqian YuDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Kunio IizukaDepartment of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Yuji TakanoTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Yoshihisa KakutoDepartment of Psychiatry, Miyagi Psychiatric Center, Natori, Japan.
Shunichi FunakoshiDepartment of Psychiatry, Miyagi Psychiatric Center, Natori, Japan.
Takashi OnoDepartment of Psychiatry, Miyagi Psychiatric Center, Natori, Japan.
Junko ItoDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Yasuto KuniiDepartment of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Mizuki HinoDepartment of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Atsuko NagaokaDepartment of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Yasushi IwasakiDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
Hidenaga YamamoriDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Yuka YasudaDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Michiko FujimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Hirotsugu AzechiMolecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan.
Noriko KudoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Ryota HashimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Hirooki YabeDepartment of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
Yuko SaitoDepartment of Pathology and Laboratory Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Nobuo FuseTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Ryuta KawashimaDivision of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Yasuyuki TakiDivision of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Hiroaki TomitaDepartment of Disaster Psychiatry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Tohoku University · JPNational Center of Neurology and Psychiatry · JPFukushima Medical University · JPAichi Medical University · JPMiyagi Prefectural Hospital Organization · JPNiigata University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have indicated associations between several OLIG2 gene single-nucleotide polymorphisms (SNPs) and susceptibility to schizophrenia among Caucasians. Consistent with these findings, postmortem brain and diffusion tensor imaging studies have indicated that the schizophrenia-risk-associated allele (A) in the OLIG2 SNP rs1059004 predicts lower OLIG2 gene expression in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia patients and reduced white matter (WM) integrity of the corona radiata in normal brains among Caucasians. In an effort to replicate the association between this variant and WM integrity among healthy Japanese, we found that the number of A alleles was positively correlated with WM integrity in some fiber tracts, including the right posterior limb of the internal capsule, and with mean blood flow in a widespread area, including the inferior frontal operculum, orbital area, and triangular gyrus. Because the A allele affected WM integrity in opposite directions in Japanese and Caucasians, we investigated a possible association between the OLIG2 gene SNPs and the expression level of OLIG2 transcripts in postmortem DLPFCs. We evaluated rs1059004 and additional SNPs in the 5' upstream and 3' downstream regions of rs1059004 to cover the broader region of the OLIG2 gene. The 2 SNPs (rs1059004 and rs9653711) had opposite effects on OLIG2 gene expression in the DLPFC in Japanese and Caucasians. These findings suggest ethnicity-dependent opposite effects of OLIG2 gene SNPs on WM integrity and OLIG2 gene expression in the brain, which may partially explain the failures in replicating associations between genetic variants and psychiatric phenotypes among ethnicities.

Indexed as

Asian PeopleSchizophreniaWhite PeopleAdultDiagnosisDiffusion Tensor ImagingGene ExpressionGenetic Predisposition to DiseaseHumansInternal CapsuleOligodendrocyte Transcription Factor 2Polymorphism, Single NucleotidePrefrontal CortexWhite MatterOLIG2 protein, humanOligodendrocyte Transcription Factor 2OLIG2 polymorphismschizophreniawhite matter integrity/cerebral blood flow/OLIG2 gene expression/ethnic difference

Identifiers

PMID32285113
PMCPMC7846078
OpenAlexW3016167237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.